Skip to main content
Fig. 2 | Cardiovascular Diabetology

Fig. 2

From: Transposition of cardiovascular outcome trial effects to the real-world population of patients with type 2 diabetes

Fig. 2

Comparison between observed and transposed effects. The forest plot reports hazard ratios and 95% confidence intervals (C.I.) for 3-point major adverse cardiovascular events (3P-MACE) and the second co-primary endpoint in DECLARE in the original cardiovascular outcome trial (CVOTs, black) and after transposition to the target population (red). HHF hospitalization for heat failure, CVD cardiovascular death

Back to article page

Cardiovascular Diabetology

ISSN: 1475-2840